
Unlocking New Therapeutic Pathways: PRL1 and PRL3 in Tumour Growth and Cancer Immunotherapy
Read More
Harnessing Spatial Biology to Uncover Cell-Cell Interactions in Pancreatic Cancer

Nr1h2: A KEY TRANSCRIPTION FACTOR UNLOCKS NEW POTENTIAL IN STEM CELL-BASED EMBRYO MODELS

IMPACT at IMCB: Fostering Postdoctoral Collaboration and Development

Celebrating IMCB's Success at SME Tech Day 2024

SCIENTISTS DISCOVER HOW EXCESSIVE RED MEAT CONSUMPTION INCREASES COLORECTAL CANCER RISK

Celebrating Mentorship Excellence: STAR Mentor Award 2024

Understanding How Enterovirus-A71 Causes Neurodegeneration in Human Motor Neurons

UNVEILING THE DIVERSITY OF MOTILE CILIA: A BREAKTHROUGH IN UNDERSTANDING CILIARY FUNCTION

IMCB Leads Collaborative Efforts at the SIMM-IMCB-ZIDD Joint Research Symposium: Advancing Biomedical Research Between China and Singapore

New research shows patients with rare cancers face increased risk of developing anxiety and depression

IMCB signs agreement with Cell Genesis Pte Ltd to advance cell therapy research for diabetes

A*STAR Scientists: Building Tomorrow's Science Today

REDUCING STRESS IN FARMED FISH: A NEW TOOL FOR IMPROVING AQUACULTURE PRACTICES

NEW RESEARCH REVEALS LINK BETWEEN SPINAL MUSCULAR ATROPHY (SMA) AND LIVER DAMAGE

INTERNATIONAL RESEARCH TEAM UNVEILS IMPACT OF EAST ASIAN GENE VARIANT ON TYPE 2 DIABETES RISK

The surprising interplay between metabolism and mind

Scientists Discover How Deadly Skin Cancer Evades The Human Immune System

Congratulations to Associate Professor Su Xinyi on her official appointment as Executive Director of IMCB, effective from March 1, 2024.

Nurturing the next generation of scientific talents